ArticleTherapeutic advances in medical oncology2026
Real-world outcomes and safety of inetetamab plus pyrotinib and chemotherapy in HER2-positive metastatic breast cancer: A multicenter retrospective study.
Fan Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.